The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Condition:   Refractory/Relapsed Autoimmune Hemolytic Anemia Intervention:   Drug: Zanubrutinib Sponsor:   Institute of Hematology & Blood Diseases Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials